Updated statement on use of respiratory therapies with regards to CoVID-19

31 March 2021

The ASA’s statement on the safe use of respiratory therapies to minimise spread of CoVID-19 has been updated. Key changes include: 

  • Emphasis on assessing risk in each situation, including risk of the individual having CoVID-19, risk of the current setting and risk of cessation of treatment 
  • Highlighting the importance of seeking expert input to ensure that cessation of therapy is safe, and if not determining where appropriate care can be provided 
  • Specific recommendations for hospital, home and hotel quarantine settings 

You can find an updated copy of the statement here.